AI assistant
Sending…
AEON Biopharma, Inc. — Director's Dealing 2021
Feb 9, 2021
35234_dirs_2021-02-08_74d567cc-222c-4705-a3cf-8b98a822d587.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Priveterra Acquisition Corp. (PMGM)
CIK: 0001837607
Period of Report: 2021-02-08
Reporting Person: Meredith David (Chief Legal Officer&Secretary)
More from AEON Biopharma, Inc.
Interim / Quarterly Report
2026
May 14
Earnings Release
2026
May 14
Annual Report
2026
Apr 29
Proxy Solicitation & Information Statement
2026
Apr 29
Director's Dealing
2026
Feb 20
Capital/Financing Update
2026
Feb 18
Capital/Financing Update
2026
Feb 9
Major Shareholding Notification
2026
Jan 29
Director's Dealing
2026
Jan 29
Major Shareholding Notification
2026
Jan 29